Kezar Life Sciences, Inc. (KZR) Balance Sheet Annual - Discounting Cash Flows
KZR
Kezar Life Sciences, Inc.
KZR (NASDAQ)
Period Ending: 2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
Report Filing: 2025-03-25 2024-03-14 2023-03-14 2022-03-17 2021-03-11 2020-03-12 2019-03-26 2017-12-31 2016-12-31
Total Current Assets 137.5 206.9 285.7 211.7 144.8 81.13 109.8 52.33 10.49
Cash and Short Term Investments 132.2 201.4 276.6 208.4 140.4 78.21 107.4 51.03 9.75
Cash & Equivalents 41.75 35.49 40.46 62.88 21.23 14.95 24.18 51.03 9.75
Short Term Investments 90.5 165.9 236.1 145.5 119.2 63.26 83.25 0 0
Receivables 0.424 2.29 0 0 0.766 0.642 0 0 0
Inventory 0 0 0 0 0 0 0 0 0
Other Current Assets 4.82 3.29 9.16 3.3 3.6 2.28 2.37 1.29 0.74
Total Assets 144.7 221.2 299.6 217.9 151.8 89.51 114.7 54.22 11.42
Total Non-Current Assets 7.19 14.29 13.85 6.28 7.03 8.38 4.88 1.9 0.937
Property, Plant and Equipment 4.78 8.69 13.17 6 6.75 8.1 4.59 1.54 0.862
Goodwill and Intangible Assets 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0.013 0.013
Deferred Tax Assets 0 0 0 0 0 0 0 0 0
Other Long Term Assets 2.42 5.59 0.674 0.282 0.282 0.282 0.282 0.343 0.062
Total Current Liabilities 20.33 17.74 11 8.21 6.44 6 3.34 1.48 0.651
Accounts Payable 3.65 8.25 2.48 2.03 2.36 0.823 0.193 0.547 0.466
Notes Payable/Short Term Debt 8.74 3.01 2.56 1.2 1.04 0.9 0 0 0
Tax Payables 0 0 0 0 0 0 0 0 0
Deferred Revenue 0 0 0 0 0 0 0 0 0
Other Current Liabilities 7.93 6.48 5.95 4.99 3.04 4.28 3.14 0.937 0.185
Total Liabilities 27.77 33.66 29.7 21.06 10.86 11.47 5.88 79.91 28.85
Total Non-Current Liabilities 7.44 15.92 18.7 12.85 4.42 5.46 2.55 78.42 28.2
Total Long Term Debt 7.44 15.92 18.7 12.85 4.42 5.46 0 0 0
Deferred Tax Liabilities Non-Current 0 0 0 0 0 0 0 0 0
Deferred Revenue Non-Current 0 0 0 0 0 0 0 0 0
Capital Lease Obligations 5.85 5.85 11.43 4.42 4.42 5.46 0 0 0
Other Long Term Liabilities -5.85 -5.85 -11.43 -4.42 -4.42 -5.46 2.55 78.42 28.2
Total Equity 116.9 187.6 269.9 196.9 141 78.05 108.8 -25.69 -17.43
Non-Controlling Interest 0 0 0 0 0 0 0 0 0
Total Stockholders' Equity 116.9 187.6 269.9 196.9 141 78.05 108.8 -25.69 -17.43
Retained Earnings -434.5 -350.8 -248.9 -180.7 -126 -84.28 -49.2 -26.03 -17.51
Accumulated Other Earnings -0.162 -0.13 -0.923 -0.291 -0.137 -0.196 -0.203 -0.111 -0.15
Common Stock 0.007 0.073 0.068 0.056 0.046 0.019 0.019 0.001 0.001
Preferred Stock 0 0 0 0 0 0 0 77.93 28.18
Additional Paid in Capital 551.6 538.4 519.6 377.8 267.1 162.5 158.2 -77.48 -27.94
Total Liabilities & Total Equity 144.7 221.2 299.6 217.9 151.8 89.51 114.7 54.22 11.42
Total Liabilities & Shareholders' Equity 144.7 221.2 299.6 217.9 151.8 89.51 114.7 54.22 11.42
Total Investments 90.5 165.9 236.1 145.5 119.2 63.26 83.25 0.013 0.013
Total Debt 16.18 18.93 21.26 14.04 5.46 6.36 0 0 0
Net Debt -25.57 -16.56 -19.19 -48.84 -15.76 -8.59 -24.18 -51.03 -9.75
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program